Glucocorticoids suppress T cell function by up-regulating microRNA-98

Arthritis and Rheumatism

Volumn 65, Issue 7, 2013, Pages 1882-1890

  Davis, Trevor E ^a,b,d   Kis Toth, Katalin ^a   Szanto, Attila ^c   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 13; MESSENGER RNA; METHYLPREDNISOLONE; MICRORNA; MICRORNA 98; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; NORMAL HUMAN; OPTIMAL DRUG DOSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

GENE EXPRESSION PROFILING; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; MICRORNAS; T-LYMPHOCYTES; UP-REGULATION;

EID: 84879847718     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37966     Document Type: Article

References (50)

1. Xu L, Xu Z, Xu M,. Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis. Clin Exp Immunol 2009; 158: 26-30.
2. + T-lymphocytes after IV methyl-prednisolone for multiple sclerosis relapse. J Neuroimmunol 2008; 204: 131-5.
3. Ashwell JD, Lu FW, Vacchio MS,. Glucocorticoids in T cell development and function [review]. Annu Rev Immunol 2000; 18: 309-45.
4. Papamichail M, Tsokos G, Tsawdaroglou N, Sekeris CE,. Immunocytochemical demonstration of glucocorticoid receptors in different cell types and their translocation from the cytoplasm to the cell nucleus in the presence of dexamethasone. Exp Cell Res 1980; 125: 490-3.
5. Ing NH,. Steroid hormones regulate gene expression posttranscriptionally by altering the stabilities of messenger RNAs [review]. Biol Reprod 2005; 72: 1290-6.
6. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function [review]. Cell 2004; 116: 281-97.
7. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J, et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005; 201: 1367-73.
8. Mulijo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K,. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005; 202: 261-9.
9. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, et al. Foxp3-dependent microRNA 155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009; 30: 80-91.
10. Li Q-J, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147-61.
11. Stahl HF, Fauti T, Ullrich N, Bopp T, Kubach J, Rust W, et al. miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression. PLoS One 2009; 4: e7158.
12. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, et al. miRNA profiling of naive, effector and memory CD8 T cells. PloS One 2007; 10: e1020.
13. Ceribelli A, Yao B, Dominguez-Gutierrez PR, Nahid MA, Satoh M, Chan EK,. MicroRNAs in systemic rheumatic diseases [review]. Arthritis Res Ther 2011; 13: 229.
14. Amarilyo G, La Cava A,. miRNA in systemic lupus erythematosus [review]. Clin Immunol 2012; 144: 26-31.
15. Harada M, Pokrovskaja-Tamm K, Soderhall S, Heyman M, Grander D, Corcoran M,. Involvement of the miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia. Leuk Lymphoma 2012; 53: 2041-50.
16. Molitoris JK, McColl KS, Distelhorst CW,. Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17∼92 contributes to the induction of Bim and initiation of apoptosis. Mol Endocrinol 2011; 25: 409-20.
17. Zheng Y, Xiong S, Jiang P, Liu R, Liu X, Qian J, et al. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. Free Radic Biol Med 2012; 52: 1307-17.
18. Liu L, Walker EA, Kissane S, Khan I, Murray PI, Rauz S, et al. Gene expression and miR profiles of human corneal fibroblasts in response to dexamethasone. Invest Ophthalmol Vis Sci 2011; 52: 7282-8.
19. Smith LK, Shah RR, Cidlowsk JA,. Glucocorticoids modulate microRNA expression and processing. J Biol Chem 2010; 285: 36698-708.
20. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T,. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011; 27: 431-2.
21. Maere S, Heymans K, Kuiper M,. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005; 21: 3448-9.
22. Al-Habat SM, Rogers HJ,. Methylprednisolone pharmacokinetics after intravenous and oral administration. Br J Clin Pharmacol 1989; 27: 285-90.
23. Lanza L, Scudeletti M, Puppo F, Bosco O, Peirano L, Filaci G, et al. Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol 1996; 103: 482-90.
24. Zacharchuk CM, Mercep M, Chakraborti PK, Simons SS Jr, Ashwell JD,. Programmed T lymphocyte death: cell activation- and steroid-induced pathways are mutually antagonistic. J Immunol 1990; 145: 4037-45.
25. Jiang W, Zhu Z, Bhatia N, Agarwal R, Thompson HJ,. Mechanisms of energy restriction: effects of corticosterone on cell growth, cell cycle machinery, and apoptosis [review]. Cancer Res 2002; 62: 5280-7.
26. Garcia-Gras EA, Chi P, Thompson EA,. Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3′-untranslated region of the mRNA. J Bio Chem 2000; 275: 22001-8.
27. Wu J, Li Y, Dietz J, Lala DS,. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions. Mol Endocrinol 2004; 18: 53-62.
28. Antonova L, Mueller CR,. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Genes Chromosomes Cancer 2008; 47: 341-52.
29. De Kruif MD, Lemaire LC, Giebelen IA, Groot AP, Pater JM, van den Pangaart PS, et al. Effects of prednisolone on the systemic release of mediators of cell-mediated cytotoxicity during human endotoxemia. Shock 2008; 29: 458-61.
30. Schroen DJ, Brinckerhoff CE,. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. Gene Expr 1996; 6: 197-207.
31. Richards DF, Fernandez M, Caulfield J, Hawrylowicz CM,. Glucocorticoids drive human CD8+ T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur J Immunol 2000; 30: 2344-54.
32. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR,. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 2002; 22: 7802-11.
33. Issa R, Xie S, Khorasani N, Sukkar M, Adcock IM, Lee K-Y, et al. Corticosteroid inhibition of growth-related oncogene protein-α via mitogen-activated kinase phosphatase-1 in airway smooth muscle cells. J Immunol 2007; 178: 7366-75.
34. Toh M-L, Yang Y, Leech M, Santos L, Morand EF,. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1β and glucocorticoids. Arthritis Rheum 2004; 50: 3118-28.
35. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604-7.
36. Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J,. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through up-regulation of miR-98/let-7. Circ Res 2003; 108: 305-13.
37. Wang S, Tang Y, Cui H, Zhao X, Luo X, Pan W, et al. Let-7/miR-98 regulate Fas and Fas-mediated apoptosis. Genes Immun 2011; 12: 149-54.
38. Kumar M, Ahmad T, Sharma A, Mabalirajan U, Kulshreshtha A, Agrawal A, et al. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol 2011; 128: 1077-85.
39. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010; 33: 607-1.
40. Wang Y, Lee LC,. MicroRNA and cancer-focus on apoptosis [review]. J Cell Mol Med 2009; 13: 12-23.
41. Umemura M, Kawabe T, Shudo K, Kidoya H, Fukui M, Asano M, et al. Involvement of IL-17 in Fas ligand-induced inflammation. Int Immunol 2004; 16: 1099-108.
42. Wajant H, Pfizenmaier K, Scheurich P,. Non-apoptotic Fas signaling [review]. Cytokine Growth Factor Rev 2003; 14: 53-66.
43. Baumann S, Dostert A, Novac N, Bauer A, Schmid W, Fas SC, et al. Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood 2005; 106: 617-25.
44. Zhu H, Shyh-Chang N, Segre AV, Shinoda G, Shah SP, Einhorn WS, et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011; 147: 81-94.
45. Tsokos GC,. Systemic lupus erythematosus [review]. N Engl J Med 2011; 365: 2110-21.
46. Shin MS, Lee N, Kang I,. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells. Curr Opin Rheumatol 2011; 23: 444-8.
47. + regulatory T cells in human lupus erythematosus. Arch Dermatol Res 2009; 301: 71-81.
48. Stagakis E, Bertsias G, Verginis P, Nakou M, Hatziapostolou M, Kritikos H, et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 2011; 70: 1496-506.
49. Wang G, Tam LS, Kwan BC, Li EK, Chow KM, Luk CC, et al. Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol 2012; 31: 435-40.
50. Wang G, Tam L-S, Li EK, Kwan BC, Chow K-M, Luk CC, et al. Serum and urinary cell-free miR-146a and miR-155 in patients with systemic lupus erythematosus. J Rheumatol 2010; 37: 2516-22.